DrGeorge Mylonas, BEng, MSc, DIC, PhD
Associate Professor in Robotics and Technology in Cancer
Department of Surgery & Cancer - Faculty of Medicine
Orcid identifier0000-0003-3725-5843 (opens in a new tab)
- Associate Professor in Robotics and Technology in CancerDepartment of Surgery & Cancer - Faculty of Medicine
- Room 415B, Bessemer Building, South Kensington Campus, United Kingdom
RESEARCH
HARMS Lab: Human-centred Automation, Robotics and Monitoring for Surgery
The HARMS lab (www.harms-lab.org) employs Patient- and Surgeon-specific approaches, Perceptually-Enabled Methodologies and Frugal Innovation through Human-Centred Design to deliver enabling and disruptive solutions in the areas of Monitoring, Automation and Robotics for Surgery. Our Human-Centred paradigm starts with the people we are designing for and ends with new solutions that are tailored to suit their needs. The people we are designing for are primarily the Patient and the Surgeon, but of equal importance are the Health Provider, the Tax Payer and the Nurse.
Our Human-Centred paradigm is based on the following first principles:
Patient- and surgeon-specific methodologies with the aim to minimize and eventually eliminate invasiveness, optimise outcome, improve ergonomics and promote personalisation.
Frugal innovation to provide affordable robotic surgery capabilities, allow infrastructure re-purposing and negligible theatre footprint.
Perceptually-enabled functionalities to improve ergonomics, reduce mental fatigue, facilitate automation and increase safety in the operating theatre.
We aim to:
Develop enabling technologies that introduce radical change, augment performance and capabilities by making robotic surgery attainable and accessible.
Introduce disruptive innovation that pushes the boundaries by proposing new paradigms in minimally invasive surgery.
Deliver solutions that are open to adoption and adaptation to a wide range of applications, in and out of clinical settings.A significant part of the HARMS Lab work stems from the desire to disrupt the oligarchical status quo of the robotic surgery market, democratise and accelerate robotic surgery adoption. This will be achieved by giving smaller hospitals and poorer health systems the opportunity to adopt robotic technology or even develop it and customize it in-house.
Research Topics
Research topics include the development of robotic platforms for a wide range of procedures for non-invasive diagnosis and ultra-minimally invasive therapy. Procedures include but are not limited to:
Single Incision and Natural Orifice Laparoscopic Surgery,
Endoscopic Microsurgery (including Neurosurgery),
Natural Orifice Gastrointestinal approaches,
Wide-area automated Optical Biopsy.
Perceptually-enabled methodologies such as gaze-tracking, haptics, multi-sensor fusion, artificial intelligence and robotic assistance in the operating theatre are being investigated for improving training, collaboration and safety.
Modern manufacturing modalities and principles, such as 3D printing and soft robotics, are also central to the HARMS Lab investigations.
Extensive description of past and ongoing research can be found on the lab webpage: www.harms-lab.org
The HARMS lab (www.harms-lab.org) employs Patient- and Surgeon-specific approaches, Perceptually-Enabled Methodologies and Frugal Innovation through Human-Centred Design to deliver enabling and disruptive solutions in the areas of Monitoring, Automation and Robotics for Surgery. Our Human-Centred paradigm starts with the people we are designing for and ends with new solutions that are tailored to suit their needs. The people we are designing for are primarily the Patient and the Surgeon, but of equal importance are the Health Provider, the Tax Payer and the Nurse.
Our Human-Centred paradigm is based on the following first principles:
Patient- and surgeon-specific methodologies with the aim to minimize and eventually eliminate invasiveness, optimise outcome, improve ergonomics and promote personalisation.
Frugal innovation to provide affordable robotic surgery capabilities, allow infrastructure re-purposing and negligible theatre footprint.
Perceptually-enabled functionalities to improve ergonomics, reduce mental fatigue, facilitate automation and increase safety in the operating theatre.
We aim to:
Develop enabling technologies that introduce radical change, augment performance and capabilities by making robotic surgery attainable and accessible.
Introduce disruptive innovation that pushes the boundaries by proposing new paradigms in minimally invasive surgery.
Deliver solutions that are open to adoption and adaptation to a wide range of applications, in and out of clinical settings.A significant part of the HARMS Lab work stems from the desire to disrupt the oligarchical status quo of the robotic surgery market, democratise and accelerate robotic surgery adoption. This will be achieved by giving smaller hospitals and poorer health systems the opportunity to adopt robotic technology or even develop it and customize it in-house.
Research Topics
Research topics include the development of robotic platforms for a wide range of procedures for non-invasive diagnosis and ultra-minimally invasive therapy. Procedures include but are not limited to:
Single Incision and Natural Orifice Laparoscopic Surgery,
Endoscopic Microsurgery (including Neurosurgery),
Natural Orifice Gastrointestinal approaches,
Wide-area automated Optical Biopsy.
Perceptually-enabled methodologies such as gaze-tracking, haptics, multi-sensor fusion, artificial intelligence and robotic assistance in the operating theatre are being investigated for improving training, collaboration and safety.
Modern manufacturing modalities and principles, such as 3D printing and soft robotics, are also central to the HARMS Lab investigations.
Extensive description of past and ongoing research can be found on the lab webpage: www.harms-lab.org
GRANTS
- CENTRE / HUBPB5890 Hamlyn-Multiscale Medical Robotics Centre 2.0Multi-Scale Medical Robotics Center Limited1 May 2025 - 30 Apr 2030
- STANDARD - CALLSelf-propelled soft robotic endoscopes for next-generation gastrointestinal surgery and beyondEngineering & Physical Science Research Council (E1 Jul 2023 - 30 Jun 2028
- STANDARD - CALLPA2925-CoDietEU Underwrite - Innovate UK1 Jan 2023 - 31 Dec 2026
- STANDARD - CALLImperial College Medical Technologies Overarching New Entreprise (MedTechONE)Wellcome Trust1 Jul 2022 - 30 Jun 2026
- GRANTFlexible endoluminal soft robot for GI cancer treatmentMulti-Scale Medical Robotics Center Ltd18 Sep 2020 - 30 Apr 2030
- INTERNAL SCHEMEDevelopment of a prototype Sensorimotor Mapping of Anorectal Tone and Function (SMART) device.Imperial College Healthcare NHS Trust- BRC Funding